Ranibizumab for retinal neovascularization

Ophthalmology

Volumn 118, Issue 5, 2011, Pages

  Jorge, Rodrigo ^a   Oliveira, Rodrigo S ^a   Messias, Andre ^a   Almeida, Felipe P ^a   Strambe, Mario L ^a   Costa, Rogério A ^a   Scott, Ingrid U ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; CLINICAL ARTICLE; DIABETIC RETINOPATHY; EYE TOXICITY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LENS; LETTER; MALE; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; TREATMENT OUTCOME;

EID: 79955600686     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.12.025     Document Type: Letter

References (5)

1. Early Treatment Diabetic Retinopathy Study Research Group Fundus photographic risk factors for progression of diabetic retinopathy ETDRS report number 12 Ophthalmology 98 1991 823 833
2. J.F. Vander, J.S. Duker, and W.E. Benson Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation Ophthalmology 98 1991 1575 1579
3. R. Jorge, R.A. Costa, and D. Calucci ; Intravitreal bevacizumab (AVASTIN) for persistent new vessels in diabetic retinopathy (IBEPE study) Retina 26 2006 1006 1013 (Pubitemid 44973219)
4. The Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision Results of a randomized trialDiabetic Retinopathy Vitrectomy Study Report 3 Ophthalmology 95 1988 1307 1320
5. S.J. Bakri, M.R. Snyder, and J.M. Reid Pharmacokinetics of intravitreal ranibizumab (Lucentis) Ophthalmology 114 2007 2179 2182 (Pubitemid 350181137)